Salesforce Ventures came back for a round which increased the professional coaching service’s valuation from $1.7bn to $4.7bn in eight months.

Quanta Services is contributing to a PIPE deal for the IAC-backed internet service provider’s reverse takeover valuing the combined business at $1.66bn.

Bayer, Pfizer and Ipsen-backed cancer therapeutics developer Pyxis Oncology priced its shares at the top of its range.

The dental technology developer’s proposed listing on the New York Stock Exchange would mark an exit for Henry Crown and Company.

The Ariad Pharmaceuticals-backed cancer therapeutics developer floated at the top of its range following $120m in venture funding.

Shernaz Daver, formerly an advisory partner at GV, has joined the venture firm as a senior operating partner and CMO to assist its expansion and growth projects.

The touchscreen technology developer, which counts Foxconn, Corning, LG-MRI, E Ink and Global Inkjet as investors, has completed its series B round.

Rabobank participated in the $15m series A portion of an equity-and-grant round for the pollination monitoring system provider.

Zoom was among the investors in a $20.5m round for BrightHire, the creator of a recruitment assistant tool for use on its platform.

Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.